Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in Spanish.
Allergic rhinitis
Clinical practice
Health related quality of life
Questionnaire
Validation study
Journal
Allergologia et immunopathologia
ISSN: 1578-1267
Titre abrégé: Allergol Immunopathol (Madr)
Pays: Singapore
ID NLM: 0370073
Informations de publication
Date de publication:
Historique:
received:
03
05
2019
revised:
15
07
2019
accepted:
26
07
2019
pubmed:
12
10
2019
medline:
24
11
2020
entrez:
12
10
2019
Statut:
ppublish
Résumé
the RhinAsthma Patient Perspective (RAPP) is the only available tool to assess HRQoL in daily practice. The aim of this study is to cross-culturally validate the RAPP in Spanish. The RAPP was translated into Spanish. Adult patients receiving usual care for asthma and allergic rhinitis (AR) were recruited consecutively and assessed twice with a four-week interval between visits to test the psychometric properties of the questionnaire. 149 patients (62.8% female) with a mean age of 37.7 years completed the study. Exploratory and confirmatory factor analysis confirmed the uni-dimensional structure of the questionnaire. Internal consistency (0.73 at visit 1; 0.87 at visit 2), convergent and discriminant validity (p<.05 at both visits) were satisfactory. Reliability was confirmed by an ICC of 0.69 and a CCC of 0.74. Responsiveness was supported by a significant association with VAS (r=0.28, p<0.003) and ACT (r=-0.35, p<0.01). The minimal clinical difference (MID) value in the analyzed population was 2. The Spanish version of RAPP was demonstrated to have satisfactory psychometric properties and is a valid, reliable and responsive tool for the assessment of asthma and AR HRQoL in clinical practice.
Identifiants
pubmed: 31601503
pii: S0301-0546(19)30112-0
doi: 10.1016/j.aller.2019.07.006
pii:
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
165-169Informations de copyright
Copyright © 2019 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.